glp-1 rheumatoid arthritis study Medications and Arthritis: What a New Shows Everyone talks about Ozempic and

The medication has demonstrated significant benefits in reducing HbA1c levels and can promote weight loss as a secondary effect, though it's important to note that Ozempic is not licensed for weight management in the UK (Wegovy is the semaglutide product licensed for weight management)

The cornerstone of safe GLP-1 therapy is open communication with your healthcare team

Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong Kong

Potentiation of cisplatin cytotoxicity in resistant ovarian cancer SKOV3/cisplatin cells by quercetin pre-treatment